| An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management G Raghu, HR Collard, JJ Egan, FJ Martinez, J Behr, KK Brown, TV Colby, ... American journal of respiratory and critical care medicine 183 (6), 788-824, 2011 | 8729 | 2011 |
| Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis L Richeldi, RM Du Bois, G Raghu, A Azuma, KK Brown, U Costabel, ... New England Journal of Medicine 370 (22), 2071-2082, 2014 | 4310 | 2014 |
| An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias WD Travis, U Costabel, DM Hansell, TE King Jr, DA Lynch, AG Nicholson, ... American journal of respiratory and critical care medicine 188 (6), 733-748, 2013 | 3743 | 2013 |
| Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials PW Noble, C Albera, WZ Bradford, U Costabel, MK Glassberg, ... The Lancet 377 (9779), 1760-1769, 2011 | 2256 | 2011 |
| ATS/ERS/WASOG statement on sarcoidosis. American thoracic society/European respiratory society/world association of sarcoidosis and other granulomatous disorders GW Hunninghake, U Costabel, M Ando, R Baughman, JF Cordier, ... Sarcoidosis, vasculitis, and diffuse lung diseases: official journal of …, 1999 | 1515 | 1999 |
| An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline G Raghu, B Rochwerg, Y Zhang, CAC Garcia, A Azuma, J Behr, ... American journal of respiratory and critical care medicine 192 (2), e3-e19, 2015 | 1420 | 2015 |
| High-dose acetylcysteine in idiopathic pulmonary fibrosis M Demedts, J Behr, R Buhl, U Costabel, R Dekhuijzen, HM Jansen, ... New England Journal of Medicine 353 (21), 2229-2242, 2005 | 1340 | 2005 |
| Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis L Richeldi, U Costabel, M Selman, DS Kim, DM Hansell, AG Nicholson, ... New England Journal of Medicine 365 (12), 1079-1087, 2011 | 1299 | 2011 |
| An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease KC Meyer, G Raghu, RP Baughman, KK Brown, U Costabel, RM Du Bois, ... American journal of respiratory and critical care medicine 185 (9), 1004-1014, 2012 | 1080 | 2012 |
| American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias WD Travis, TE King, ED Bateman, DA Lynch, F Capron, TV Colby, ... American journal of respiratory and critical care medicine 165 (2), 277-304, 2002 | 973 | 2002 |
| Clinical diagnosis of hypersensitivity pneumonitis Y Lacasse, M Selman, U Costabel, JC Dalphin, M Ando, F Morell, ... American journal of respiratory and critical care medicine 168 (8), 952-958, 2003 | 767 | 2003 |
| Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement RP Baughman, M Drent, M Kavuru, MA Judson, U Costabel, R du Bois, ... American journal of respiratory and critical care medicine 174 (7), 795-802, 2006 | 763 | 2006 |
| European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis SR Johnson, JF Cordier, R Lazor, V Cottin, U Costabel, S Harari, ... European Respiratory Journal 35 (1), 14-26, 2010 | 690 | 2010 |
| Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial TE King, C Albera, WZ Bradford, U Costabel, P Hormel, L Lancaster, ... The Lancet 374 (9685), 222-228, 2009 | 647 | 2009 |
| ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis statement committee. American thoracic society. European respiratory society. World association for sarcoidosis and other … U Costabel, GW Hunninghake European Respiratory Journal 14 (4), 735-737, 1999 | 616 | 1999 |
| ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: update of the international … WD Travis, U Costabel, DM Hansell, TE King Jr, DA Lynch, AG Nicholson, ... Am J Respir Crit Care Med 188 (6), 733-48, 2013 | 604 | 2013 |
| Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial G Raghu, J Behr, KK Brown, JJ Egan, SM Kawut, KR Flaherty, FJ Martinez, ... Annals of internal medicine 158 (9), 641-649, 2013 | 537 | 2013 |
| Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference RM Du Bois, D Weycker, C Albera, WZ Bradford, U Costabel, A Kartashov, ... American journal of respiratory and critical care medicine 184 (12), 1382-1389, 2011 | 518 | 2011 |
| Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference RM Bois, D Weycker, C Albera, WZ Bradford, U Costabel, A Kartashov, ... American journal of respiratory and critical care medicine 183 (9), 1231-1237, 2011 | 518 | 2011 |
| Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis Y Eishi, M Suga, I Ishige, D Kobayashi, T Yamada, T Takemura, ... Journal of clinical microbiology 40 (1), 198-204, 2002 | 495 | 2002 |
Marjolein DrentHoogleraar Pulmonologie, i.h.b. ILD, FHML Maastricht UniversityVerified email at ildcare.nl
